留学作业Case Analysis代写-辉瑞公司商业案例分析。本文是一篇留学生Case Analysis作业代写范例，主要内容是讲述辉瑞公司是世界上最大的以研究为基础的制药和生物医学组织之一，致力于为这两个人和两种生物寻找、创造、组装和推广医生推荐的处方。中央司令部设在纽约市。并对辉瑞公司的商业案例进行分析研究。
本留学作业提到辉瑞公司于1849年由德国科学专家和商业人士查尔斯·辉瑞及其堂兄查尔斯·埃哈特（糖果商）在纽约布鲁克林成立，名为查尔斯·辉瑞公司。该组织当时是一家精细合成物质企业，由辉瑞的父亲提供2500美元的信贷。他们的第一个产品是一种令人满意的桑托宁，一种用于治疗肠道蠕虫的抗寄生虫药，在19世纪中期的美国是一种典型的疾病。下面就一起来参考这篇留学作业Case Analysis代写范文。
Pfizer, Inc., is one of the world's biggest research-based pharmaceutical and biomedical organizations, devoted to finding, creating, assembling, and promoting physician recommended prescriptions for the two people and creatures. Central command are in New York City.
1849
Pfizer was established in Brooklyn, New York, in 1849 as Charles Pfizer and Company by the German scientific expert and business person Charles Pfizer and his cousin Charles Erhart, a confectioner. The organization, at that point a fine-synthetic substances business, was financed with a $2,500 credit from Pfizer's dad. Their first item is an agreeable type of santonin — an antiparasitic used to treat intestinal worms, a typical distress in mid-nineteenth century America.
1862
As interest for painkillers, additives, and disinfectants takes off during the Civil War, Pfizer extends creation of tartaric corrosive and cream of tartar just as other fundamental medications to help address the issues of the Union Army.
随着人们对止痛药、添加剂和消毒剂的兴趣在内战期间高涨，辉瑞公司将酒石腐蚀剂和酒石膏的开发扩展到其他基本药物，以帮助解决联邦军队的问题。
1868
The organization presently has a significantly expanded product offering and 150 new workers.
该组织目前有一个显著扩大的产品供应和150名新工人。
When Erhart kicked the bucket in 1891, Pfizer dealt with the organization. In 1900 he documented an endorsement of consolidation; the organization would remain secretly held until 1942. In 1905 Pfizer's most youthful child, Emile, was designated leader of the organization; Charles Pfizer kicked the bucket the next year.
1891年，当埃哈特破产时，辉瑞与该组织打交道。1900年，他记录了对合并的支持；该组织将一直秘密关押到1942年。1905年，辉瑞最年轻的孩子埃米尔被指定为该组织的领导人；第二年，查尔斯·辉瑞破产了。
In 1941, in line with the U.S. government, Pfizer—the main organization utilizing aging innovation to mass-produce penicillin—sped up creation to treat Allied officers battling in World War II. The organization experienced noteworthy extension during the next decade with the production of its universal and horticultural divisions and its Pfizer pharmaceutical deals power, just as its association with the Japanese organization Taito to create and disseminate anti-toxins (1955; Pfizer completely procured Taito in 1983). Pfizer kept on venturing into the 1970s, with acquisitions, for example, the pharmaceutical and compound producer Mack Illertissen (1971).
1941年，为了与美国政府保持一致，辉瑞公司（Pfizer）这家利用老化创新大规模生产青霉素的主要组织加快了青霉素的生产，以治疗二战中作战的盟军军官。该组织在接下来的十年中经历了值得注意的扩展，生产了其通用和园艺部门以及辉瑞制药公司，正如其与日本组织Taito合作创建和传播抗毒素一样。辉瑞一直冒险进入20世纪70年代，收购了制药和化合物生产商Mack Illertissen。
1999
Pfizer takes the medication revelation procedure to another degree of proficiency with the opening of the Discovery Technology Center in Cambridge, Massachusetts. Using the developing information on quality families, the Center's crucial to advance new, progressively effective models for finding drug competitors.
随着位于马萨诸塞州剑桥的发现技术中心的成立，辉瑞将药物披露程序提升到了另一个熟练程度。利用有关优质家族的不断发展的信息，该中心对于推进新的、逐步有效的模式以寻找药物竞争对手至关重要。
2003
On April 16, 2003 Pfizer Inc and Pharmacia Corporation join activities, uniting two of the world's quickest developing and most inventive organizations.
2003年4月16日，辉瑞公司（Pfizer Inc.）和法玛西亚公司（Pharmacia Corporation）联合开展活动，联合了世界上发展最快、最具创造力的两个组织
2004
Caduet® , the main single pill that treats both hypertension and elevated cholesterol, is propelled.
Caduet是治疗高血压和胆固醇升高的主要单药片，正在推进。
2015
In 2015 Pfizer declared that it would converge with Allergan, the Dublin-based creator of Botox, in an arrangement that was esteemed at $160 billion and would permit Pfizer to reincorporate abroad consequently bringing down its U.S. government charges. Notwithstanding, in April 2016 the U.S. government acquainted guidelines with forestall such expense reversal bargains, and presently the merger was cancelled.
2015年，辉瑞宣布将与总部位于都柏林的肉毒杆菌素生产商Allergan达成协议，协议金额高达1600亿美元，并将允许辉瑞在海外重新组建公司，从而降低其美国政府的收费。尽管如此，2016年4月，美国政府熟悉了阻止此类费用逆转交易的指导方针，目前该合并被取消。
2017
Pfizer and Corning Incorporated report joint efforts that have empowered the modernisation of pharmaceutical bundling with the presentation of Corning Valor Glass.
辉瑞（Pfizer）和康宁公司（Corning Incorporated）报告称，通过展示康宁Valor Glass，双方共同努力实现了医药捆绑产品的现代化。
2019-2020
Pfizer, earning a yearly income of 53.64 Billion$, positions 61 on the Fortune 500 rundown and holds the fifth spot in the best 10 pharmaceutical organizations of 2019 (Geneticengineering and biotechnology news, 2020).
辉瑞的年收入为536.4亿美元，在《财富》500强中排名61位，在2019年十大制药机构中排名第五（基因工程和生物技术新闻，2020）。
PRODUCTS 产品
A portion of the significant results of Pfizer are :- 辉瑞的部分重要成果包括：
Ativan Injection (lorazepam)阿替凡注射液（劳拉西泮）
Atorvastatin阿托伐他汀
Atracurium besilate (atracurium besilate)苯磺酸阿曲库铵（苯磺酸阿曲库铵）
Cisplatin顺铂
Colestid (colestipol hydrochloride)科尔斯蒂德（盐酸科尔斯蒂波尔
Cresemba (isavuconazole)伊萨武康唑
Cyklokapron (tranexamic corrosive)氨甲环己烷腐蚀性
Cytarabine阿糖胞苷
Cytotec (misoprostol)米索前列醇
Vincristine sulfate (vincristine sulfate)硫酸长春新碱（硫酸长春新碱）
Vizimpro (dacomitinib monohydrate)一水达科替尼
Voriconazole伏立康唑
Prostin E2 (dinoprostone)前列腺素E2（地诺前列酮）
Prostin VR (alprostadil)前列地尔
Solu-Cortef (hydrocortisone sodium succinate)氢化可的松琥珀酸钠
Solu-Medrone (methylprednisolone sodium succinate)甲基强的松龙琥珀酸钠
Somavert (pegvisomant)
Pfizer's most conspicuous items incorporate the stimulant Zoloft, the erectile-brokenness tranquilize Viagra, and the upper and antianxiety sedate Xanax.
辉瑞最引人注目的产品包括兴奋剂佐洛特、勃起障碍镇定剂伟哥和抗焦虑镇静剂Xanax。
Research and Development Group, which centers around the disclosure of little particles and related modalities; and the Biotherapeutics Research and Development Group, which centers around huge atom explore, including antibodies. In 2007, Pfizer put $8.1 billion in innovative work, the biggest R&D interest in the pharmaceutical business .
研发小组，其中心是小粒子和相关模式的披露；以及生物治疗研究与开发小组，该小组以包括抗体在内的巨大原子探索为中心。2007年，辉瑞在创新工作上投入了81亿美元，这是制药行业最大的研发兴趣。
Pfizer has R&D offices in the accompanying areas: 辉瑞在相关地区设有研发办公室：
• Pearl River, New York 纽约珠江
• Groton, Connecticut (Largest R&D site) 康涅狄格州格罗顿（最大的研发基地）
• Andover, Massachusetts 马萨诸塞州安多弗
• La Jolla, California 加利福尼亚州拉荷亚
• South San Francisco, California 加利福尼亚州南旧金山
• Cambridge, Massachusetts 马萨诸塞州剑桥
• St. Louis, Missouri 密苏里州圣路易斯
• Sandwich, United Kingdom 英国三明治
• Cambridge, United Kingdom. 英国剑桥
• Morrisville, North Carolina 北卡罗来纳州莫里斯维尔
• Chennai, India 印度金奈
Assembling 装配
Assembling is the creation of items for use or deal utilizing work and machines, apparatuses, substance or natural preparing or definition and is the pith of auxiliary industry. The term may allude to a scope of human action from craftsmanship to innovative yet is most usually applied to mechanical structure, in which crude materials from essential industry are changed into completed products for an enormous scope.
装配是为使用或交易利用工作和机器、仪器、物质或自然准备或定义而创造的物品，是辅助工业的精髓。该术语可能暗指从工艺到创新的人类活动范围，但最常用于机械结构，在机械结构中，基本工业的原材料在很大范围内被转化为成品。
Rundown of nations by assembling yield 通过集合收益率对国家进行分类
Rundown of top 20 assembling nations by all out benefit of assembling in us dollars for its prominent year as indicated by world.
世界排名前20位的装配国在其突出年份以美元进行装配的全部收益排名。
Activities 活动
Pfizer works through two business sections - Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH is the bigger fragment, representing some 60% of all out income. That fragment centers around the improvement and commercialization of novel prescriptions and antibodies and purchaser medicinal services items. It is occupied with zonesincluding inward prescription, oncology, irritation and immunology, and uncommon maladies.
辉瑞通过两个业务部门开展工作——辉瑞创新健康（IH）和辉瑞基本健康（EH）。IH是更大的部分，约占全部收入的60%。该片段围绕着新处方、抗体和医疗服务项目的改进和商业化。该区域包括内向处方、肿瘤学、刺激性和免疫学以及罕见疾病。
Sales and Marketing 销售和营销
Pfizer markets its pharmaceuticals truly to pros, crisis facilities, chaperons, sedate authorities, retailers, focuses, advantage the officials firms, managed care affiliations, business social affairs, government workplaces, and to patients themselves. A huge segment of its arrangements are driven through rebate wholesalers including McKesson, Cardinal Health, and AmerisourceBergen, which combined record for around 40% of yearly earnings.
辉瑞将其药品真正销售给专业人士、危机处理机构、陪同人员、稳重的权威机构、零售商、焦点、优势公司、管理医疗机构、商业社会事务、政府工作场所以及患者自己。其很大一部分安排是由折扣批发商推动的，包括麦凯森、红衣主教健康和AmerisourceBergen，这些批发商的年收入加起来约占创纪录的40%。
Financial Performance 财务业绩
Except for 2016, Pfizer's incomes have been slanting descending for as far back as quite a long while. Overall gain took a lofty decay from 2014 through 2016 however bounced back in 2017.
除2016年外，辉瑞的收入在很长一段时间内一直在下降。从2014年到2016年，整体收益大幅下降，但在2017年反弹。
On Tuesday, Pfizer said it presently expects 2018 income of between $53 billion and $55 billion, contrasted and an earlier conjecture of $53.5 billion to $55.5 billion. The organization is the most recent U.S. drugmaker to trim its yearly income gauge because of a reinforcing dollar.
周二，辉瑞表示，目前预计2018年收入将在530亿至550亿美元之间，而此前的预测为535亿至555亿美元。由于美元走强，该组织是最近一家调整年度收入标准的美国制药商。
Financial Reports: 财务报告：
Stock price (5Y range):股价（5Y区间）：
ONCOLOGY: 肿瘤学：
In oncology Total 40 Projects are going on in which 14 activities are in Phase1, 10 are in phase2, 11 ventures in stage 3, while 5 undertakings are in enlistment process.
在肿瘤学中，共有40个项目正在进行，其中14项活动处于第1阶段，10项处于第2阶段，11项风险投资处于第3阶段，5项事业正在招募过程中。
Associations and Strategy 协会和战略
In May 2015, Pfizer and a Bar-Ilan University research facility declared an organization dependent on the improvement of therapeutic DNA nanotechnology.
2015年5月，辉瑞公司和巴伊兰大学的一个研究机构宣布成立一个依靠改进治疗性DNA纳米技术的组织。
Understanding that to quicken development we can't work alone, we team up with patients gatherings, industry, specialists and others to arrive at our objectives.
认识到要加快发展，我们不能独自工作，我们与患者聚会、行业、专家和其他人合作，以实现我们的目标。
Mergers and Acquisitions 合并和收购
Pfizer has made various acquisitions to reinforce its improvement arrange and marketed contributions and avert misfortunes from patent lapse.
辉瑞进行了各种收购，以加强其改进和营销贡献，并避免专利失效带来的不幸。
In 2019 Pfizer gained Array BioPharma Inc., which creates medications to treat malignant growth, for about $11.4 billion. Pfizer said the arrangement would reinforce its biopharmaceutical business and its oncology-related contributions.
2019年，辉瑞以约114亿美元收购了Array BioPharma Inc.，该公司生产治疗恶性肿瘤的药物。辉瑞表示，这一安排将加强其生物制药业务及其与肿瘤相关的贡献。
Likewise in 2019 Pfizer procured Therachon, which is creating uncommon hereditary illness medications, for some $340 million or more $470 million in potential achievement installments.
类似地，2019年，辉瑞以约3.4亿美元或4.7亿美元的潜在成就分期付款购买了Therachon，该公司正在开发罕见的遗传疾病药物。
Pfizer has desire to turn into the chief pharmaceutical firm by 2020. It has been tested in that objective by various patent lapses and bombed merger endeavors, however has been effective in getting administrative endorsements to dispatch and obtain new items.
辉瑞希望到2020年成为首席制药公司。在这一目标上，它已经通过各种专利失效和被轰炸的合并努力进行了测试，然而，它在获得行政批准以发送和获取新项目方面是有效的。
Pfizer's Next 3 Years: What Investors Can Expect 辉瑞未来三年：投资者能期待什么
Pfizer (NYSE) conveyed probably the most grounded exhibition in quite a while a year ago. Its stock bounced over 20% in 2018, conveniently beating the more extensive market files. The huge pharma organization topped off the year with a strong final quarter that beat Wall Street gauges.
辉瑞（NYSE）在一年前举办了一场可能是最有根据的展览。2018年，其股票反弹超过20%，轻松击败了更广泛的市场文件。这家大型制药公司在今年的最后一个季度表现强劲，超过了华尔街的标准。
Yet, Pfizer additionally disillusioned speculators with its 2019 direction. The drugmaker's officials talked a lot about its needs during the current year and the future in Pfizer's Q4 profit telephone call on Tuesday. This is what speculators can anticipate.
然而，辉瑞对2019年的发展方向也让投机者大失所望。在周二辉瑞第四季度的利润电话会议上，该制药公司的官员就其在今年和未来的需求进行了大量讨论。这是投机者可以预见的。
An exceptional 2019 例外的2019年
Make an effort not to scan for Pfizer to build up this year. Furthermore, that applies to both the top and primary concerns. The midpoints of Pfizer's pay and benefit heading for 2019 truly reflect slight decreases from the association's 2018 results. Pfizer CFO Frank D'Amelio explained why: a $2.6 billion headwind from things that have lost or after a short time will lose domination, and a $900 million negative impact from outside exchange rates.
努力避免辉瑞今年的业绩增长。此外，这适用于首要问题和主要问题。辉瑞2019年薪酬福利的中点确实反映出该协会2018年的业绩略有下降。辉瑞首席财务官弗兰克·达梅里奥解释了原因：失去或在短时间后失去支配地位的事物带来的26亿美元逆风，以及外部汇率带来的9亿美元负面影响。
Conclusion 结论
Another outrageous year in 2020 2020年又是令人震惊的一年
New Pfizer CEO Albert Bourla perceived in his comments during the Q4 benefit call that 2020 would in like manner be an outrageous year. Bourla said the impact of the loss of limitation (LOE) for Lyrica will continue hurting Pfizer into one year from now.
辉瑞新任首席执行官阿尔伯特·博拉（AlbertBoura）在第四季度的福利电话会议上发表的评论中表示，2020年同样将是一个令人震惊的一年。Bourla表示，Lyrica失去限制的影响将持续到一年后。
D'Amelio communicated that Pfizer will "need to work our way through 2020" as it adjusts to the loss of particularity for Lyrica, including later that 2020 will be "a troublesome year."
达梅里奥表示，辉瑞将“努力工作到2020年”，以适应Lyrica失去特殊性的情况，包括2020年将是“麻烦的一年”
Regardless, Pfizer could begin to see some improvement in the second half of 2020. Bourla referenced "the pivotal moment that is happening after the June-July of 2020" - an induction to when year-over-year assessments should look better in light of the fact that Lyrica loses limitation in June 2019.
无论如何，辉瑞可能在2020年下半年开始看到一些改善。Bourla提到了“2020年6月至7月之后发生的关键时刻”——鉴于Lyrica在2019年6月失去限制，这是一个归纳，说明什么时候年度评估应该看起来更好。
An explosive vital turning point in 2021 2021的爆炸性关键转折点
2021 is a substitute story totally. D'Amelio said Pfizer would like to create solid salary improvement and significantly more grounded benefit advancement beginning in a couple of years. He called 2021 as "a gesture point in the rhythm of the business."
2021完全是一个替代故事。D'Amelio表示，辉瑞希望在未来几年内实现稳固的薪酬提升，并大幅提升福利待遇。他将2021称为“商业节奏中的一个姿态点”
There are a couple of reasons 2021 will be a colossal pivotal occasion for Pfizer. The negative impact of things that have lost limitation will rot distinctly. D'Amelio even insinuated 2021 as the start of a "LOE free" period. Pfizer's pipeline, which Bourla said the association sees as its "most essential pipeline ever," should pass on a couple of new meds with blockbuster potential.
留学作业在Case Analysis最后提出2021对辉瑞来说将是一个巨大的关键时刻，有几个原因。失去限制的事物的负面影响将明显腐烂。达梅里奥甚至暗示2021是“无爱情”时期的开始。博拉说，辉瑞的管道被该协会视为其“有史以来最重要的管道”，应该会传递一些具有巨大潜力的新药。本站提供各国各专业留学生作业写作指导服务，如有需要可咨询本平台。